Fisk Ventures LLC is a private venture capital fund of H. Fisk Johnson, Ph.D., Chairman of the Board, the Chairman and Chief Executive Officer of S.C. Johnson & Son, Inc.
Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. They accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.
They have three primary divisions — Bioscience, Diagnostic and Hospital – which develop, produce and market our innovative products and services to medical professionals in more than 90 countries around the world.
They have three primary divisions — Bioscience, Diagnostic and Hospital – which develop, produce and market our innovative products and services to medical professionals in more than 90 countries around the world.
OrbiMed Advisors is a leading investment firm dedicated exclusively to the healthcare sector. With $7 billion in assets under management, OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies. OrbiMed’s team manages a series of private equity funds, public equity funds, royalty and debt funds, and other investment vehicles.
JAFCO is a global investment management company headquartered in Tokyo. For more than 35 years, JAFCO has invested in exceptional companies with differentiated technology in sectors including electronics, IT services, software, distribution and biotechnology. JAFCO successfully maintains a well-balanced portfolio by raising corporate values of investee companies and establishing a value chain of private equity investment.
Prolog Ventures is a life science venture capital firm. Since launching its inaugural fund in 2001, Prolog has partnered with more than 30 early-stage companies. The firm invests in traditional healthcare opportunities as well as selected areas that until recently received little venture capital attention: analytical platforms for diagnostic, industrial and other testing applications; bioscience-based green technology solutions; and consumer nutrition and wellness products.
For more investor information, email